Skip to content

Glycemic Response Testing

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02020798
Enrollment
38
Registered
2013-12-25
Start date
2013-12-31
Completion date
2014-02-28
Last updated
2014-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glycemic Response

Brief summary

The purpose of this study is to assess whether food ingredient(s) affect glycemic responses.

Interventions

OTHERDietary Intervention

Sponsors

Glycemic Index Laboratories, Inc
CollaboratorINDUSTRY
PepsiCo Global R&D
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Subject is 18-75 years of age * Subject has a body mass index (BMI) ≥ 20.0 and \< 35 kg/m² at screening (visit 1). * Subject has normal fasting serum glucose (\<7.0mmol/L capillary corresponding to whole blood glucose \<6.3mmol/L). * Subject has no health conditions that would prevent him from fulfilling the study requirements as judged by the Investigator on the basis of medical history. * Subject understands the study procedures and signs forms providing informed consent to participate in the study and authorization for release of relevant protected health information to the study investigator.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Incremental area under the blood glucose response curve0-2 hoursGlycemic response calculated from individual glucose measurements upon consumption of control and experimental test food products. The individual glucose measurements will be collected at baseline (prior to consumption of each test food product) and over a 2-hour period following the initiation of consumption of each test food product. The primary outcome is differential treatment-effect on the time-concentration glucose curve over the 2 hours post consumption of each test food product.

Secondary

MeasureTime frame
Rate of decline in blood glucose, peak blood glucose, peak insulin and adjusted time concentration area for insulin0-2 hours

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026